Retatrutide is a newly developed therapy that acts as a potent GLP-1 receptor agonist. This innovative treatment holds significant promise for regulating type 2 diabetes. By mimicking the actions of natural GLP-1, https://tedmase260786.ssnblog.com/37899903/retatrutide-a-novel-glp-1-receptor-agonist-for-diabetes-management